Literature DB >> 16234879

Canadian Cardiovascular Society Consensus Conference: peripheral arterial disease - executive summary.

Beth L Abramson1, Vic Huckell, Sonia Anand, Tom Forbes, Anil Gupta, Ken Harris, Asad Junaid, Tom Lindsay, Finlay McAlister, Andre Roussin, Jacqueline Saw, Koon Kang Teo, Alexander G Turpie, Subodh Verma.   

Abstract

This Consensus Conference has been supported by the Canadian Cardiovascular Society. The process is dynamic, with intentional structure that requires peer review and feedback from cardiovascular specialists across Canada. The writing and review panel encompassed a broad range of specialists caring for the patient with peripheral arterial disease (PAD). PAD is an often asymptomatic, underdiagnosed, under-recognized and undertreated condition. It is associated with significant morbidity and cardiac mortality. Until recently, little attention has focused on the evaluation and treatment of the disease process itself. The goal of the present paper is to ensure better treatment, to reduce both morbidity and mortality in the patient with vascular disease and, importantly, to serve as a guide to the busy clinician. Although the focus is PAD, there are chapters on thoracic and abdominal aortic disease, renal arterial disease and the evidence supporting management. Screening and diagnostic techniques including history and physical examination as well as noninvasive imaging techniques are reviewed. Medical management for patients with vascular disease including prevention and risk reduction is graded based on evidence, including both pharmacological and nonpharmacological management strategies, followed by an introduction to newer percutaneous techniques. Finally, surgical treatment for claudication including new concepts on the perioperative risk assessment for patients undergoing major vascular surgery is discussed.

Entities:  

Mesh:

Year:  2005        PMID: 16234879

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  24 in total

1.  One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.

Authors:  Kim G Smolderen; Alan Bell; Yang Lei; Eric A Cohen; P Gabriel Steg; Deepak L Bhatt; Elizabeth M Mahoney
Journal:  Can J Cardiol       Date:  2010-10       Impact factor: 5.223

2.  Loss of taste with clopidogrel.

Authors:  Andrew J Cave; Diane W Cox; Ozair Vicaruddin
Journal:  Can Fam Physician       Date:  2008-02       Impact factor: 3.275

3.  Predictors of an abnormal postexercise ankle brachial index: Importance of the lowest ankle pressure in calculating the resting ankle brachial index.

Authors:  David W J Armstrong; Colleen Tobin; Murray F Matangi
Journal:  Clin Cardiol       Date:  2017-11-27       Impact factor: 2.882

Review 4.  Paclitaxel Drug-Eluting Stents in Peripheral Arterial Disease: A Health Technology Assessment.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2015-11-01

5.  Peripheral arterial disease: lack of awareness in Canada.

Authors:  Marge Lovell; Kenneth Harris; Thomas Forbes; Gwen Twillman; Beth Abramson; Michael H Criqui; Paul Schroeder; Emile R Mohler; Alan T Hirsch
Journal:  Can J Cardiol       Date:  2009-01       Impact factor: 5.223

6.  Oscillometric measurement of ankle-brachial index.

Authors:  Andrea M MacDougall; Vikas Tandon; Merne P Wilson; Thomas W Wilson
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

7.  Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-09-01

8.  Three-dimensional T2-weighted MRI of the human femoral arterial vessel wall at 3.0 Tesla.

Authors:  Zhuoli Zhang; Zhaoyang Fan; Timothy J Carroll; YiuCho Chung; Peter Weale; Renate Jerecic; Debiao Li
Journal:  Invest Radiol       Date:  2009-09       Impact factor: 6.016

9.  Management of atherothrombotic risk factors in high-risk Canadian outpatients.

Authors:  Alan Bell; Michael D Hill; Robert J Herman; Manon Girard; Eric Cohen
Journal:  Can J Cardiol       Date:  2009-06       Impact factor: 5.223

10.  Does screening for peripheral arterial disease improve risk stratification for patients at intermediate risk for coronary artery disease?

Authors:  Michelle Greiver
Journal:  Open Med       Date:  2007-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.